506 related articles for article (PubMed ID: 18384770)
41. Interaction of midazolam and morphine in the spinal cord of the rat.
Yanez A; Sabbe MB; Stevens CW; Yaksh TL
Neuropharmacology; 1990 Apr; 29(4):359-64. PubMed ID: 2160622
[TBL] [Abstract][Full Text] [Related]
42. Galanin acts at GalR1 receptors in spinal antinociception: synergy with morphine and AP-5.
Hua XY; Hayes CS; Hofer A; Fitzsimmons B; Kilk K; Langel U; Bartfai T; Yaksh TL
J Pharmacol Exp Ther; 2004 Feb; 308(2):574-82. PubMed ID: 14610237
[TBL] [Abstract][Full Text] [Related]
43. Majonoside-R2, a major constituent of Vietnamese ginseng, attenuates opioid-induced antinociception.
Huong NT; Matsumoto K; Yamasaki K; Duc NM; Nham NT; Watanabe H
Pharmacol Biochem Behav; 1997; 57(1-2):285-91. PubMed ID: 9164584
[TBL] [Abstract][Full Text] [Related]
44. Enhancement of spinal N-methyl-D-aspartate receptor function by remifentanil action at delta-opioid receptors as a mechanism for acute opioid-induced hyperalgesia or tolerance.
Zhao M; Joo DT
Anesthesiology; 2008 Aug; 109(2):308-17. PubMed ID: 18648240
[TBL] [Abstract][Full Text] [Related]
45. Effect of diazepam and midazolam on the antinociceptive effect of morphine, metamizol and indomethacin in mice.
Pakulska W; Czarnecka E
Pharmazie; 2001 Jan; 56(1):89-91. PubMed ID: 11210678
[TBL] [Abstract][Full Text] [Related]
46. Differential effects of intrathecal midazolam on morphine-induced antinociception in the rat: role of spinal opioid receptors.
Rattan AK; McDonald JS; Tejwani GA
Anesth Analg; 1991 Aug; 73(2):124-31. PubMed ID: 1649558
[TBL] [Abstract][Full Text] [Related]
47. Substance P potentiates thermal hyperalgesia induced by intrathecal administration of D-serine in rats.
Zhang YH; Shu YS; Zhao ZQ
Acta Pharmacol Sin; 2001 Sep; 22(9):817-20. PubMed ID: 11749863
[TBL] [Abstract][Full Text] [Related]
48. Supraspinal flumazenil inhibits the antianalgesic action of spinal dynorphin A (1-17).
Rady JJ; Holmes BB; Fujimoto JM
Pharmacol Biochem Behav; 1998 May; 60(1):245-54. PubMed ID: 9610949
[TBL] [Abstract][Full Text] [Related]
49. Systemic coadministration of chloramphenicol with intravenous but not intracerebroventricular morphine markedly increases morphine antinociception and delays development of antinociceptive tolerance in rats.
Smith MT; Nielsen CK; Lim-Fraser MY; Wright AW; Lau M
Drug Metab Dispos; 2000 Feb; 28(2):236-44. PubMed ID: 10640523
[TBL] [Abstract][Full Text] [Related]
50. DAMGO and 6beta-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain model and high intrinsic efficacy in the isolated rat vas deferens.
Al-Khrasani M; Spetea M; Friedmann T; Riba P; Király K; Schmidhammer H; Furst S
Brain Res Bull; 2007 Oct; 74(5):369-75. PubMed ID: 17845912
[TBL] [Abstract][Full Text] [Related]
51. Antinociceptive properties of propofol: involvement of spinal cord gamma-aminobutyric acid(A) receptors.
Nadeson R; Goodchild CS
J Pharmacol Exp Ther; 1997 Sep; 282(3):1181-6. PubMed ID: 9316824
[TBL] [Abstract][Full Text] [Related]
52. D2-like but not D1-like dopamine receptors are involved in the ventrolateral orbital cortex-induced antinociception: a GABAergic modulation mechanism.
Sheng HY; Qu CL; Huo FQ; Du JQ; Tang JS
Exp Neurol; 2009 Jan; 215(1):128-34. PubMed ID: 18952080
[TBL] [Abstract][Full Text] [Related]
53. Ketamine enhances the efficacy to and delays the development of tolerance to electroacupuncture-induced antinociception in rats.
Huang C; Long H; Shi YS; Han JS; Wan Y
Neurosci Lett; 2005 Feb; 375(2):138-42. PubMed ID: 15670657
[TBL] [Abstract][Full Text] [Related]
54. Anti-nociceptive and anti-allodynic effects of a high affinity NOP hexapeptide [Ac-RY(3-Cl)YRWR-NH2] (Syn 1020) in rodents.
Khroyan TV; Polgar WE; Orduna J; Zaveri NT; Judd AK; Tuttle DJ; Sanchez A; Toll L
Eur J Pharmacol; 2007 Mar; 560(1):29-35. PubMed ID: 17303110
[TBL] [Abstract][Full Text] [Related]
55. Intrathecal antinociceptive interaction between the NMDA antagonist ketamine and the opioids, morphine and biphalin.
Kosson D; Klinowiecka A; Kosson P; Bonney I; Carr DB; Mayzner-Zawadzka E; Lipkowski AW
Eur J Pain; 2008 Jul; 12(5):611-6. PubMed ID: 18068383
[TBL] [Abstract][Full Text] [Related]
56. Interactions between an N-methyl-D-aspartate antagonist and low-efficacy opioid receptor agonists in assays of schedule-controlled responding and thermal nociception.
Fischer BD; Dykstra LA
J Pharmacol Exp Ther; 2006 Sep; 318(3):1300-6. PubMed ID: 16772537
[TBL] [Abstract][Full Text] [Related]
57. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats.
Hernández-Delgadillo GP; Cruz SL
Eur J Pharmacol; 2006 Sep; 546(1-3):54-9. PubMed ID: 16914138
[TBL] [Abstract][Full Text] [Related]
58. The antinociceptive effects and pharmacological properties of JM-1232(-): a novel isoindoline derivative.
Chiba S; Nishiyama T; Yamada Y
Anesth Analg; 2009 Mar; 108(3):1008-14. PubMed ID: 19224817
[TBL] [Abstract][Full Text] [Related]
59. Prevention and reversal of morphine tolerance by the analgesic neuroactive steroid alphadolone.
Goodchild CS; Kolosov A; Geng L; Winter LL; Nadeson R
Pain Med; 2009; 10(5):890-901. PubMed ID: 19682273
[TBL] [Abstract][Full Text] [Related]
60. Differential modulation by baclofen on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the formalin test.
Chung KM; Kim YH; Song DK; Huh SO; Suh HW
Neuropeptides; 1999 Dec; 33(6):534-41. PubMed ID: 10657537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
